South Korean solar cells maker OCI Holdings is rapidly increasing production in the US despite President Donald Trump’s vow to slash clean energy subsidies, in what the company calls a ...

Hanmi Pharmaceutical Group Chairwoman Song Young-sook’s plan to merge the drug developer with OCI Group, a local chemical firm, ended up in failure, Thursday, following the appointment of all ...

OCI Group, a chemical, solar power and electric car battery material maker, and drug developer Hanmi Pharmaceutical Group, will merge under a new corporate body to enhance competitiveness in the ...

The comments follow a flurry of deal activity at OCI in response to pressure from US activist investor Jeff Ubben, as well as within Sawiris’ NNS Group family office. Sawiris, whose wealth ...

OCI Group, a chemical, solar power and electric car battery material maker, looks to merge with drugmaker Hanmi Pharmaceutical Group, as the two entities seek business synergies to create the ...

Hassan Badrawi, CEO of OCI Global: "OCI entered 2025 with positive momentum, following a year marked by significant portfolio ...

The expected merger between OCI Group and Hanmi Group has been called off after a general meeting of shareholders at Hanmi Science, the holding company of Korea's leading drug firm Hanmi ...

OCI's plant would be the world's first new commercial ... subsidies worth roughly $145 per ton cover the difference, said CRU Group fertilizers analyst Alexander Derricott. To make the economics ...